Filters: Keyword is Health Care Costs [Clear All Filters]
"AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency virus-infection health care in the United States." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 35, no. 5 (2002): 606-10. Abstract
"A budget impact analysis of rapid human immunodeficiency virus screening in Veterans Administration emergency departments." The Journal of emergency medicine 42, no. 6 (2012): 719-26. Abstract
"Comparison of two VA laboratory data repositories indicates that missing data vary despite originating from the same source." Medical care 47, no. 1 (2009): 121-4. Abstract
"Cost and utilization outcomes of opioid-dependence treatments." The American journal of managed care 17 Suppl 8 (2011): S235-48. Abstract
"Cost evaluation of evidence-based treatments." Addiction science & clinical practice 5, no. 2 (2010): 44-51. Abstract
"The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S76-82. Abstract
"Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa." Proceedings of the National Academy of Sciences of the United States of America 110, no. 19 (2013): 7952-7. Abstract
"Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S113-8. Abstract
"Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India." PloS one 5, no. 9 (2010). Abstract
"Cost-effectiveness of HIV treatment as prevention in serodiscordant couples." The New England journal of medicine 369, no. 18 (2013): 1715-25. Abstract
"Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal." PLoS medicine 6, no. 10 (2009): e1000173. Abstract
"The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial." Drug and alcohol dependence 128, no. 1-2 (2013): 90-7. Abstract
"Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 13, no. 8 (2010): 893-902. Abstract
"Expanded screening for HIV in the United States--an analysis of cost-effectiveness." The New England journal of medicine 352, no. 6 (2005): 586-95. Abstract
"Group prenatal care and perinatal outcomes: a randomized controlled trial." Obstetrics and gynecology 110, no. 2 Pt 1 (2007): 330-9. Abstract
"Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy." Antiviral therapy 7, no. 4 (2002): 257-66. Abstract
"The lifetime medical cost savings from preventing HIV in the United States." Medical care 53, no. 4 (2015): 293-301. Abstract
"Social costs of robbery and the cost-effectiveness of substance abuse treatment." Health economics 17, no. 8 (2008): 927-46. Abstract
"Task force #2--the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference." Journal of the American College of Cardiology 40, no. 4 (2002): 603-15.
"When to start antiretroviral therapy in resource-limited settings." Annals of internal medicine 151, no. 3 (2009): 157-66. Abstract
